Product Catalog
Blends
Protocols
Explore Our Products
All orders ship same day from our US facility.
Made in the USA
Peptides are precision-synthesized and lyophilized at state-of-the-art laboratories in the United States.
Frequently Asked Questions
Peptides are short chains of amino acids that occur naturally in organisms, where they act as messengers in many biological systems. While some peptides have been developed for medical use, laboratory research focuses on understanding their activity at the cellular level, examining how they impact essential processes in vitro.
Products from Direct Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Orders are typically processed and shipped within 24 hours on weekdays. Delivery times vary by location, but most domestic orders arrive within 3–5 business days. You’ll receive tracking information as soon as your order ships.
Tirz
What is Tirz?
Tirz, also known as GLP2-T, is a synthetic dual GIP and GLP-1 receptor agonist studied for its effects on metabolic signaling, insulin pathways, and energy-balance regulation. In research environments, it is investigated for its ability to modulate incretin signaling, receptor crosstalk, and systemic hormone interactions, making it a compound of interest in experimental models focused on glucose regulation, energy metabolism, and integrated endocrine responses.
Certificate of Analysis
Third-party tested for 99% purity
GLP2-T Overview
GLP2-T (tirzepatide) is a dual GIP and GLP-1 receptor agonist investigated for its ability to influence metabolic signaling, insulin pathways, and energy-balance regulation. By simultaneously engaging GIP and GLP-1 receptors, tirzepatide enables researchers to explore:
- Synergistic incretin signaling
- Insulin-related pathway modulation
- Cellular and systemic hormone interactions
This dual-agonist approach represents an important advancement in incretin research, allowing the study of integrated endocrine signaling rather than isolated receptor activity.
Frias J.P. et al., 2021History and Development
The development of GLP2-T is rooted in decades of incretin research that began with the identification of GLP-1 and GIP as key regulators of glucose homeostasis. Following the success of GLP-1 receptor agonists, researchers expanded toward dual-agonist strategies to investigate coordinated incretin signaling.
Tirzepatide was synthesized in the 2010s as a novel investigational compound with balanced activity at both GIP and GLP-1 receptors, designed to explore synergistic metabolic and endocrine effects.
Coskun T. et al., 2018Tirzepatide Structure
Research Findings
GLP2-T (tirzepatide) has been examined across structural, metabolic, molecular, and endocrine research models. Published studies explore its influence on insulin secretion dynamics, glucose regulation, receptor signaling, and intracellular hormone crosstalk.
Key Areas of Investigation
- Incretin Pathways: GIP and GLP-1 receptor activation
- Metabolic: Energy balance, glucose-related signaling
- Cellular: Receptor activity, intracellular response pathways
- Molecular: Hormone signaling integration, pathway crosstalk
Collectively, these findings suggest broad experimental utility for tirzepatide across metabolic, cellular, and molecular research domains. By engaging multiple hormone receptors simultaneously, GLP2-T provides a versatile research platform for studying glucose regulation, energy metabolism, and integrated hormonal biology.
Frias J.P. et al., NEJM 2021
